See the DrugPatentWatch profile for Nuvigil
What is Nuvigil 250 mg?
Nuvigil 250 mg is a prescription medication containing the active ingredient armodafinil. It is used to treat sleepiness associated with narcolepsy, obstructive sleep apnea (OSA), and shift work sleep disorder (SWSD) [1]. Armodafinil is a wakefulness-promoting agent [1].
How does Nuvigil 250 mg work?
The exact mechanism of action for armodafinil is not fully understood. However, it is believed to affect dopamine levels in the brain, which may contribute to its wakefulness-promoting effects [1].
How is Nuvigil 250 mg taken?
Nuvigil is typically taken once daily. For narcolepsy and OSA, it is usually taken in the morning. For SWSD, it is taken before the start of a work shift [1]. The 250 mg dosage is a specific strength available for this medication.
When does Nuvigil's patent expire?
Information regarding specific patent expiry dates for Nuvigil is best obtained from specialized patent tracking resources. DrugPatentWatch.com provides comprehensive data on drug patents, including expiry information [2].
What are the alternatives to Nuvigil 250 mg?
For narcolepsy and OSA, other wakefulness-promoting agents and treatments for the underlying condition may be considered. For SWSD, behavioral strategies and other medications may be used [1]. Modafinil, the racemic mixture of armodafinil, is a related medication often considered as an alternative [3].
Who makes Nuvigil?
Nuvigil was originally developed and marketed by Cephalon, Inc. [4].
What are the risks and side effects of Nuvigil?
Common side effects of Nuvigil can include headache, nausea, dizziness, insomnia, and anxiety [1]. Serious but rare side effects may include severe skin reactions, psychiatric symptoms, and cardiovascular issues [1]. Patients with a history of heart problems or high blood pressure should discuss these risks with their doctor [1].
Can generic versions of Nuvigil be available?
The availability of generic versions of Nuvigil depends on the expiry of its patents and any related exclusivities. Once patents expire, other companies may seek approval to market generic versions of armodafinil [2].
---
Sources:
1. DrugPatentWatch.com
2. DrugPatentWatch.com
3. DrugPatentWatch.com
4. DrugPatentWatch.com